Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Symbicort vs Seretide in Persistent Asthma (AHEAD)
NCT00242775Phase 3Completed
- Sponsor
- AstraZeneca
- Start
- May 2005
- Modality
- Orthosteric Ligands
- Countries
- 17
01
Overview
Phase 3, randomised, double-blind trial of budesonide in asthma (2 arms), sponsored by AstraZeneca. Primary endpoint: Time to first severe asthma exacerbation. Started May 2005; status: completed.
02
Drugs
budesonide
03
Conditions
asthma
Beyond the preview
Go deeper on NCT00242775.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00242775.